Martin Evans

Martin Evans

Founder at
Celixir Plc

Net worth: 2 M $ as of 2025-12-30

85 year
Health Technology
Consumer Services

Profile

Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18.92%
2026-04-20 16,855,254 ( 18.92% ) 2 M $ 2025-12-30
2024-12-02 269 ( 0% ) 35 $ 2026-07-30

Martin Evans active positions

CompaniesPositionStart
Founder 2016-12-27
Founder 2019-04-30

Former positions of Martin Evans

CompaniesPositionEnd
ROQT THER Chief Tech/Sci/R&D Officer 2024-05-22
President -
Founder -
See the detail of Martin Evans's experience

Training of Martin Evans

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

27

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology